Scarica l'app Stockscreener
18.75
33.36%
4.69
Pre-mercato:
18.25
-0.50
-2.67%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Viridian Therapeutics Inc Azioni (VRDN) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
99.81%
0.132
|
70.57 | 0.075 | 0.072 | 0.086 |
| Operating Expenses |
11.12%
122.88
|
110.58 | 106.84 | 93.94 | 83.57 |
| Benefits Costs and Expenses |
-
|
- | - | - | - |
| Costs And Expenses |
11.12%
122.88
|
110.58 | 106.84 | 93.94 | 83.57 |
| Operating Income/Loss |
206.77%
-122.75
|
-40.01 | -106.77 | -93.87 | -83.48 |
| Nonoperating Income/Loss |
55.78%
2.394
|
5.414 | 6.032 | 6.954 | 6.791 |
| Income/Loss From Continuing Operations Before Tax |
99.81%
0.132
|
70.57 | -100.73 | -86.91 | 0.086 |
| Income/Loss From Continuing Operations After Tax |
247.86%
-120.36
|
-34.60 | -100.73 | -86.91 | -76.69 |
Net Income/Loss
|
247.86%
-120.36
|
-34.60 | -100.73 | -86.91 | -76.69 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.14%
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):